Contents
Hospice general inpatient fraud occurs when a provider knowingly bills Medicare for inpatient care the patient does not need or did not receive. A patient can remain eligible for hospice while the reason for GIP has ended. If you saw symptoms settle while the higher billing continued, you may have seen the point where a care decision became a hospice fraud problem.
General inpatient hospice care is short-term care for pain control or acute or chronic symptom management that cannot be managed in another setting. The question is what requires inpatient management now, and whether that need continues on each billed day.
GIP can take place in a hospice inpatient unit, a hospital or a skilled nursing facility. The Inspector General’s description of the benefit puts the purpose ahead of the location: the patient needs symptom management that another setting cannot provide.
Hospice eligibility turns on a certified prognosis of six months or less if the illness runs its normal course. GIP adds a separate question about the level of care. The care level on the claim must follow the patient’s needs as they change.
Routine home care can be delivered in a patient’s residence, including a nursing facility. Inpatient respite relieves the primary caregiver. Continuous home care supplies crisis care at home and is paid by the hour. A qualifying full day of continuous home care pays more than a GIP day. GIP pays more than routine care or respite because it is supposed to provide more intensive inpatient care.
In its review of 2012 billing, the Inspector General reported $672 per day for GIP, compared with $151 for routine home care and $156 for inpatient respite. The rate rewarded a hospice for keeping the inpatient label after the need had passed.
Hospice GIP billing with no uncontrolled symptoms can charge Medicare for inpatient care when the patient needs only routine care. The Inspector General found hospices billing GIP for patients whose symptoms were controlled and for patients whose care could be supplied at a lower level.
Caregiver relief has its own place in the benefit. When the caregiver is unavailable and the patient needs a temporary inpatient stay for that reason, inpatient respite is the relevant level. The Inspector General found hospices collecting the higher GIP rate for stays that should have been respite.
The daily record makes the difference visible. In one Florida stay described in the Inspector General’s hospice portfolio, symptoms were managed within two days, but the patient remained in general inpatient care for 15 additional days. The original reason for admission had resolved. Medicare kept paying for an inpatient level the patient no longer needed.
Yes. A patient can leave the GIP level and continue receiving hospice care at the level their condition requires.
Hospice GIP continued stay documentation fraud can involve changing the reason recorded for inpatient care to prolong the higher billing. The admission assessment explains why GIP began. Later nursing observations, treatment responses and care decisions explain why it continued.
The whistleblowers’ complaint against Agape Senior Community alleged a direct instruction to keep the inpatient level going:
GIP nurses were to keep patients in GIP as long as possible, changing the problem being addressed to a secondary diagnosis, if necessary, to keep the patient in GIP longer.
The alleged instruction was to find another reason to keep the same level. The chart and the instruction to the nurse tell the story together. What did the patient need, what did the nurse record, and who wanted the description changed?
A continued-stay review follows the patient through the day: the symptoms, the medication or other intervention, the response, and the remaining need for inpatient management. The care plan should describe the scope and frequency of services. The nursing, physician and other service records show what actually happened. The claim shows which days the hospice charged at GIP.
Those comparisons also matter when symptoms remain uncontrolled. The Inspector General described a patient who spent 16 days in GIP with uncontrolled pain, while the hospice changed the pain medication only on the last day. Clinical need and the care actually delivered both belong beside the bill. The patient was still in pain while Medicare was paying for intensive symptom management.
The Inspector General’s March 2016 GIP report projected $268.1 million in inappropriate Medicare payments for 2012. The estimate came from a review of 565 stays.
In 20% of stays, the beneficiary never needed GIP. In another 10%, the beneficiary needed it for part of the stay but not the whole stay. A smaller group had no evidence of a hospice election or certification of terminal illness.
That middle group is the continued-stay problem. A supported admission could turn into unsupported billing later. The records explaining the initial transfer and the records explaining the last inpatient day answer different questions.
The Inspector General found inappropriate GIP billing more often in skilled nursing facilities than in other settings. For-profit hospices also billed this level inappropriately more often than nonprofit and government-owned hospices in the review of 2012 stays.
Care planning exposed another weakness. The Inspector General reported failures to meet plan-of-care requirements in 85% of GIP stays in 2012. Common omissions included the scope and frequency of services and participation by all required members of the interdisciplinary group. A plan is supposed to connect the physician, nurse, social worker and counselor to the particular patient’s needs. The missing detail is exactly what would help explain the work the inpatient rate was paying for.
The pharmacy bill can reveal a second payment alongside GIP. The Inspector General found Part D paying for drugs used primarily to relieve pain and control symptoms related to the terminal illness, even though the hospice’s daily rate already covered them. The same medication can appear in the clinical account of symptom management and in a separate payment claim.
Covenant Hospice agreed to pay $10,149,374 in its June 2015 settlement. The nonprofit operated in southern Alabama and the Florida Panhandle. The government alleged that Covenant billed Medicare, TRICARE and Medicaid for GIP that should have been billed as routine home care. Its medical records allegedly did not support the inpatient level. The price difference between care levels was the heart of the case.
Alive Hospice paid $1,548,220 in a September 2015 settlement over allegations that it billed Medicare and TennCare for GIP when patients did not qualify for that care. A former triage nurse at the Tennessee nonprofit started the whistleblower case.
Hope Hospice agreed to a July 2020 settlement of $3.2 million covering eligibility and GIP allegations. The government alleged that the Florida provider billed Medicare, Medicaid and TRICARE for medically unnecessary GIP for certain patients whose GIP stays exceeded two weeks. A former director of hospice care brought the case, connecting the clinical operation to the claims.
Medicare pays the hospice a daily rate intended to cover the patient’s health care. The business receives that rate while the cost of providing care changes with the patient’s condition, the services supplied and the setting.
Hospice Medicare Margins, a July 2019 Milliman client report commissioned by the National Partnership for Hospice Innovation, examined claims and cost reports. For fiscal 2017, it found aggregate net Medicare margins of 19.9% at for-profit hospices and 3.0% at nonprofit hospices.
The report explains why the pattern of care matters to those margins:
Hospice costs (and services) typically follow a U-shaped curve, with high intensity at the time of the patient’s admission and the time surrounding the patient’s death.
Its analysis associated higher margins with a greater share of patients in nursing and assisted living facilities and with a greater share staying over a year. More nursing and social service days per 100 patient days were associated with lower margins. For an insider looking at GIP, the sharper question is what happened when the need for intensive care changed but the higher daily billing remained.
A healthcare worker who becomes a hospice whistleblower may know both the patient’s condition and the instruction that kept the inpatient claim going. The nurse sees the response to treatment. The physician sees the clinical basis for continuing inpatient care. Billing sees the dates and rate. Revenue code 0656 identifies general inpatient care on the claim. A facility employee may see the care supplied where the patient actually stayed.
We connect those accounts to the claim and the decisions behind it. A note that symptoms were controlled, a direction to substitute another diagnosis, and later GIP claims can explain much more together than a long stay alone. The Agape allegation shows why instructions inside the business belong beside the clinical record.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
The Inspector General’s GIP audit announced in June 2023 targets patients transferred immediately from an inpatient hospital stay to GIP after hospital stays reached a diagnosis-based length-of-stay benchmark. The audit asks whether the GIP care exceeded the patient’s needs or was supplied at all. Its focus makes the hospital record and the hospice admission record especially useful together: what inpatient need remained at transfer, and what care followed?
The Centers for Medicare & Medicaid Services’ February 2026 enhanced-oversight fact sheet also describes medical review, including prepayment review, for new hospices and specified ownership changes or reactivations in Arizona, California, Nevada, Texas, Georgia and Ohio.
If you know why a hospice kept billing GIP after the inpatient need ended, speak with our whistleblower experts about those continued stays. Our experts build the case around what changed at the bedside and who kept the inpatient claims going. We stay beside you through the process and bring in hospice fraud whistleblower lawyers who understand Medicare care-level claims.